Figs 2A to D.

Overall Graft and patient survival at 90 days and 1 year. (A) Overall graft survival at 90 days, (B) Overall graft survival at 1 year, (C) Overall patient survival at 90 days, (D) Overall patient survival at 1 year. LRS grafts—<20% macrosteatosis; G1S grafts—20–29% macrosteatosis; G2S grafts—30–39% macrosteatosis; and G3S grafts—≥40% macrosteatosis. LRS grafts as the reference: Recipients of G1S, G2S, and G3S grafts had worse graft survival at 90 days and 1 year (p <0.001). Recipients of G2S grafts as the reference: There was no difference in 90 days or 1-year graft survival compared to G1S or G3S grafts